Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06378346 · ClinicalTrials.gov registry record · Phase 2

GU-01: Glycyrrhizin in Prostate Cancer

A Phase 2 study of Prostate Cancer, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT06378346 is a Phase 2 study of Prostate Cancer that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 60 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06378346, a Phase 2 study of Prostate Cancer, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Observation
  • DRUG Glycyrrhizin - 75 mg
  • DRUG Glycyrrhizin - 150 mg

Study Locations (1)

Illinois

  • University of Illinois - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-25
Est. Completion 2027-03
Phase Phase 2

Sponsor

University of Illinois at Chicago

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06378346

The ClinicalTrials.gov registry entry for NCT06378346 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Observation is the first listed.

NCT06378346 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06378346 about?

NCT06378346 is a clinical study titled "GU-01: Glycyrrhizin in Prostate Cancer". This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)

What is the current status of trial NCT06378346?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2024-07-25. Estimated completion is 2027-03.

What conditions does trial NCT06378346 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06378346?

The interventions under investigation include: Observation (OTHER), Glycyrrhizin - 75 mg (DRUG), Glycyrrhizin - 150 mg (DRUG).

Who is sponsoring clinical trial NCT06378346?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06378346 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.